Ambu A/S
General ticker "AMBFF" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $3.5B (TTM average)
Ambu A/S does not follow the US Stock Market performance with the rate: -42.9%.
Estimated limits based on current volatility of 0.2%: low 10.03$, high 10.07$
Factors to consider:
- Company pays dividends (irregularly): last record date 2025-12-05, amount 0.06$ (Y0.60%)
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-09-30 to 2027-09-30
- 2025-09-30 to 2026-09-30 estimated range: [10.70$, 18.12$]
- 2026-09-30 to 2027-09-30 estimated range: [10.77$, 18.03$]
Financial Metrics affecting the AMBFF estimates:
- Positive: with PPE of 45.2 at the end of fiscal year the price was neutral
- Negative: -0.92 < Industry inventory ratio change (median), % of -0.68
- Negative: negative Industry operating cash flow (median)
- Negative: 69.38 < Shareholder equity ratio, % of 78.64 <= 81.92
- Negative: 0.41 < Inventory ratio change, % of 0.74
- Positive: 11.29 < Operating profit margin, % of 12.99
- Negative: Industry earnings per price (median), % of -5.85 <= 0
- Negative: Investing cash flow per share per price, % of -1.48 <= -1.23
- Positive: 2.37 < Operating cash flow per share per price, % of 3.05
Short-term AMBFF quotes
Long-term AMBFF plot with estimates
Financial data
| YTD | 2023-09-30 | 2024-09-30 | 2025-09-30 |
|---|---|---|---|
| Operating Revenue | DKK4,775.00MM | DKK5,391.00MM | DKK6,026.00MM |
| Operating Expenses | DKK4,473.00MM | DKK4,746.00MM | DKK5,243.49MM |
| Operating Income | DKK302.00MM | DKK645.00MM | DKK782.51MM |
| Non-Operating Income | DKK-92.00MM | DKK-345.00MM | DKK-28.95MM |
| Interest Expense | DKK86.00MM | DKK27.00MM | DKK29.94MM |
| R&D Expense | DKK295.00MM | DKK325.00MM | DKK136.74MM |
| Income(Loss) | DKK210.00MM | DKK300.00MM | DKK753.56MM |
| Taxes | DKK42.00MM | DKK65.00MM | DKK145.72MM |
| Net Income(Loss)* | DKK168.00MM | DKK235.00MM | DKK607.84MM |
| Stockholders Equity | DKK5,393.00MM | DKK5,594.00MM | DKK6,024.00MM |
| Inventory | DKK907.00MM | DKK1,078.00MM | DKK1,270.00MM |
| Assets | DKK6,859.00MM | DKK7,154.00MM | DKK7,660.00MM |
| Operating Cash Flow | DKK518.00MM | DKK813.00MM | DKK789.50MM |
| Capital expenditure | DKK326.00MM | DKK289.00MM | DKK117.00MM |
| Investing Cash Flow | DKK-326.00MM | DKK-289.00MM | DKK-383.00MM |
| Financing Cash Flow | DKK-222.00MM | DKK-65.00MM | DKK-153.00MM |
| Earnings Per Share** | DKK0.64 | DKK0.88 | DKK2.28 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.